Prentiss Smith & Co’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-69,316
Closed -$3.41M 76
2022
Q1
$3.41M Sell
69,316
-71,791
-51% -$3.8M 2.05% 20
2021
Q4
$7.87M Buy
141,107
+37,875
+37% +$2.08M 3.72% 4
2021
Q3
$5.99M Buy
103,232
+36,079
+54% +$2.22M 3.04% 11
2021
Q2
$4.25M Sell
67,153
-342
-0.5% -$22.5K 2.05% 23
2021
Q1
$4.31M Buy
+67,495
New +$3.91M 2.21% 21

Other funds holding XRAY

Prentiss Smith & Co's XRAY Position: Q2 2022 in Review

Prentiss Smith & Co sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 69,316 shares — an estimated $3.41M sold.

Prentiss Smith & Co first reported a position in XRAY in Q1 2021 and held it in 5 quarters. The position peaked at $7.87M in Q4 2021. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

  • Prentiss Smith & Co reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
  • Prentiss Smith & Co sold 69,316 Dentsply Sirona shares in Q2 2022, an estimated $3.41M.
  • Prentiss Smith & Co first reported a position in Dentsply Sirona in Q1 2021 and held it in 5 quarters.
  • Prentiss Smith & Co's Dentsply Sirona position peaked at $7.87M in Q4 2021.
  • 470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on Prentiss Smith & Co's 13F filing for Q2 2022, filed 12 Aug 2022.